The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals
Open accessAbstract
Objective: Endoscopic ultrasonography (EUS) and MRI are promising tests to detect precursors and early-stage pancreatic ductal adenocarcinoma (PDAC) in high-risk individuals (HRIs). It is unclear which screening technique is to be preferred. We aimed to compare the efficacy of EUS and MRI in their ability to detect clinically relevant lesions in HRI. Design: Multicentre prospective study. The results of 139 asymptomatic HRI (>10-fold increased risk) undergoing first-time screening by EUS and MRI are described. Clinically relevant lesions were defined as solid lesions, main duct intraductal papillary mucinous neoplasms and cysts ≥10 mm. Results were compared in a blinded, independent fashion. Results: Two solid lesions (mean size 9 mm) and nine cysts ≥10 mm (mean size 17 mm) were detected in nine HRI (6%). Both solid lesions were detected by EUS only and proved to be a stage I PDAC and a multifocal pancreatic intraepithelial neoplasia 2. Of the nine cysts ≥10 mm, six were detected by both imaging techniques and three were detected by MRI only. The agreement between EUS and MRI for the detection of clinically relevant lesions was 55%. Of these clinically relevant lesions detected by both techniques, there was a good agreement for location and size. Conclusions: EUS and/or MRI detected clinically relevant pancreatic lesions in 6% of HRI. Both imaging techniques were complementary rather than interchangeable: contrary to EUS, MRI was found to be very sensitive for the detection of cystic lesions of any size; MRI, however, might have some important limitations with regard to the timely detection of solid lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784
Self-citationFrequent detection of pancreatic lesions in asymptomatic high-risk individuals
Canto, M. I., Hruban, R. H., Fishman, E. K., Kamel, I. R., Schulick, R., Zhang, Z., Topazian, M., Takahashi, N., Fletcher, J., Petersen, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.005 · Cited by 648
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
T. H. B. C. S. G., Iqbal, J., Ragone, A., Lubinski, J., Lynch, H. T., Moller, P., Ghadirian, P., Foulkes, W. D., Armel, S., Eisen, A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.483 · Cited by 252
Vasen, H. F. A., Wasser, M., van Mil, A., Tollenaar, R. A., Konstantinovski, M., Gruis, N. A., Bergman, W., Hes, F. J., Hommes, D. W., Offerhaus, G. J. A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.048 · Cited by 152
Research works printed but not linked: 21
- 10.3322/caac.20107 · DOI
- 10.1136/jmedgenet-2012-101277 · DOI
- Al-Sukhni W , Borgida A , Rothenmund H , et al . Screening for Pancreatic Cancer in a High-Risk Cohort: An Eight-Year Experience. J Gastrointest Surg 2011;16:771–83. doi:10.1007/s11605-011-1781-6 · DOI
- 10.7326/0003-4819-131-4-199908170-00003 · DOI · Paper page
- 10.1016/j.cgh.2006.02.005 · DOI · Paper page
- 10.1016/S1542-3565(04)00244-7 · DOI · Paper page
- 10.1136/gut.2008.171611 · DOI
- 10.1038/ajg.2011.65 · DOI
- 10.1038/ajg.2009.276 · DOI · Paper page
- 10.1158/1078-0432.CCR-09-3209 · DOI · Paper page
- 10.1158/1078-0432.CCR-08-0403 · DOI
- 10.1136/jmg.2004.028829 · DOI
- 10.1093/jnci/94.18.1358 · DOI
- 10.1136/jmg.2009.073429 · DOI
- 10.1136/gut.2006.108456 · DOI
- 10.2307/2529310 · DOI · Paper page
- 10.1016/S0016-5107(02)70092-8 · DOI
- 10.1007/s10689-010-9414-x · DOI · Paper page
- Shin, 2012, Radial versus linear and second look endoscopic ultrasound (EUS) improved detection of pancreatic lesions: a randomized tandem study, Gastrointest Endosc, 75, 131, 10.1016/j.gie.2012.04.037 · DOI
- 10.1016/j.bpg.2009.06.008 · DOI
- 10.1055/s-0033-1344956 · DOI
Cited by
Sorted by citations
Items 101–162 of 162
Chronische Pankreatitis und Pankreaskarzinom – Tumorrisiko und Screening
Beyer, G., D’Haese, J. G., Ormanns, S., & Mayerle, J. V. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-125407 · Cited by 7
Konings, I., Cahen, D., Harinck, F., Fockens, P., van Hooft, J. V., Poley, J., & Bruno, M. (2018) · Endoscopy International Open · doi:10.1055/a-0574-2396 · Cited by 8
“Our PDAC surveillance program has been described in detail before [13].”
MethodSelf-citationPredisposing factors for pancreatic adenocarcinoma: What is the role of imaging?
Vullierme, M., & Lagadec, M. (2016) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2016.08.018 · Cited by 8
New strategies for the early detection of pancreatic cancer
Petrone, M., & Arcidiacono, P. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1122521 · Cited by 8
Poiraud, M., Gkolfakis, P., & Arvanitakis, M. (2023) · Cancers · doi:10.3390/cancers15092547 · Cited by 5
“An older comparative prospective analysis from Harinck et al. [37] reported complementary roles for EUS imaging and magnetic resonance imaging (MRI).”
BackgroundRen, H., Mori, N., Hirasawa, M., Hamada, S., Mugikura, S., Masamune, A., & Takase, K. (2021) · Journal of Clinical Imaging Science · doi:10.25259/jcis_158_2021 · Cited by 9
Katona, B. W., Long, J. M., Ahmad, N. A., Attalla, S., Bradbury, A. R., Carpenter, E. L., Clark, D. F., Constantino, G., Das, K. K., Domchek, S. M., et al. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0161 · Cited by 10
“PDAC surveillance is generally performed through regular imaging of the pancreas with endoscopic ultrasound (EUS) or MRI, without definitive evidence showing one imaging modality is superior (16, 17).”
BackgroundLi, H. Z., Peng, C. Y., Shen, S. S., Wang, L., Zhang, S., Xu, G. F., Kong, B., Friess, H., Zou, X. P., & Lv, Y. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12875 · Cited by 8
Zhang, Y., Wang, S.-C., Qu, S., & Zhang, H. (2020) · IET Image Processing · doi:10.1049/iet-ipr.2019.1041 · Cited by 7
“Moreover, at the time of the visit, the patient has reached the advanced stage, and most of the patients died within less than one year after the diagnosis [1].”
BackgroundHigh Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers
Ibrahim, I. S., Wasser, M. N. J. M., Wu, Y., Inderson, A., Cappel, W. H. D. V. T. N., Morreau, H., Hes, F. J., Veenendaal, R. A., Putter, H., Feshtali, S., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0035 · Cited by 8
Diagnosis: A step closer to screening for curable pancreatic cancer?
Canto, M., & Hruban, R. (2015) · Nature Reviews Gastroenterology &Hepatology · doi:10.1038/nrgastro.2015.112 · Cited by 7
Pancreatic Cancer Screening and Early Detection
Rao, S. S., Song, O. K., Noda, Y., Schawkat, K., Rosenthal, M. H., & Kambadakone, A. R. (2026) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2026.01.005 · Cited by 1
Endoscopic Ultrasound in Pancreatology: Focus on Inflammatory Diseases and Interventions
Vitali, F., Zundler, S., Jesper, D., Strobel, D., Wildner, D., de Pretis, N., Frulloni, L., Crinó, S., & Neurath, M. (2023) · Visceral Medicine · doi:10.1159/000533433 · Cited by 6
“As stated by the study of Overbeek et al. [98], EUS seems to be better than MRI for the timely detection of solid lesions, but less sensitive for cystic lesions, so combinations of these two modalities should be applied [102].”
ResultSiegel, A., Friedman, M., Feldman, D., Krishnan, K., Casey, B. W., Pisuchpen, N., Kambadakone, A. R., & Chung, D. C. (2022) · Pancreatology · doi:10.1016/j.pan.2022.07.015 · Cited by 8
Pancreatic cancer screening in high-risk individuals: Ready for prime time?
Bruno, M. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.02.011 · Cited by 6
Self-citationShah, Y. R., Dahiya, D. S., Tiwari, A., Kumar, H., Gangwani, M. K., Ali, H., Hayat, U., Alsakarneh, S., Singh, S. T., Malik, S., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164706 · Cited by 7
“A study conducted by Harnick et al. on 139 high-risk individuals showed that two solid tumors of <10 mm were detected by EUS only and 25% of cysts were detected by MRI [85].”
MethodSuzuki, S., Shimoda, M., Shimazaki, J., Maruyama, T., & Nishida, K. (2018) · Journal of Investigative Surgery · doi:10.1080/08941939.2018.1452995 · Cited by 5
Performance of MRI-based surveillance for high-risk individuals for pancreatic cancer
Mucelli, R. P., Vujasinović, M., Farah-Mwais, A., Gustavsson, P., Moro, C. F., Ghorbani, P., Löhr, M. J., & Kartalis, N. (2025) · European Journal of Radiology · doi:10.1016/j.ejrad.2025.112275 · Cited by 4
Boekestijn, B., Feshtali, S., Meijer, A., Ibrahim, I., Fariña-Sarasqueta, A., Inderson, A., Bonsing, B., Webb, A., Vasen, H., & Wasser, M. (2020) · Annals of Pancreatic Cancer · doi:10.21037/apc-19-50 · Cited by 4
“MRI and EUS may be complementary to each other, rather than interchangeable (10).”
Backgroundde Moura, D. D., de Moura, E. D., Rodriguez, M., Ribeiro, I., Farias, G., Bernardo, W., Ryou, M., & Thompson, C. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.03.275 · Cited by 4
Progress report: familial pancreatic cancer
Mintziras, I., & Bartsch, D. K. (2019) · Familial Cancer · doi:10.1007/s10689-019-00125-9 · Cited by 3
Lindquist, C. M., Miller, F. H., Hammond, N., & Nikolaidis, P. (2018) · Abdominal Radiology · doi:10.1007/s00261-017-1308-z · Cited by 4
Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer
Ibrahim, I. S., Bonsing, B. A., Swijnenburg, R., Welling, L., Veenendaal, R. A., Wasser, M. N. J. M., Morreau, H. M., Inderson, A., & Vasen, H. F. A. (2016) · Familial Cancer · doi:10.1007/s10689-016-9915-3 · Cited by 4
“astating course, as seen in the first patient, be prevented? Regarding the first question, the two imaging techniques (MRI and EUS) reportedly show a high sensitivity and specificity [4], with MRI usually regarded as the best tool to identify cystic lesions and EUS as the best technique for the identification of solid…”
BackgroundPancreatic cancer: Future challenges and new perspectives for an early diagnosis
Cocca, S., Pontillo, G., Lupo, M., Lieto, R., Marocchi, M., Marsico, M., Dell'Aquila, E., Mangiafico, S., Grande, G., Conigliaro, R., et al. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i2.97248 · Cited by 3
Pancreatic Cancer Screening among High-risk Individuals
Turner, K. M., & Patel, S. H. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.03.002 · Cited by 3
A Novel Diagnostic Imaging Method for the Early Detection of Pancreatic Cancer
Kikuyama, M. (2023) · Diagnostics · doi:10.3390/diagnostics13122080 · Cited by 4
“CT and MRI are also limited in diagnosing PDAC [14,15], although these methods provide a clear image of the abdominal organ.”
BackgroundThe present situation of early diagnosis for pancreatic cancer: ―膵癌早期診断研究会における多施設研究の結果をもとに―
Kanno, A., Masamune, A., Hanada, K., Maguchi, H., Shimizu, Y., Ueki, T., Hasebe, O., Ohtsuka, T., Nakamura, M., Takenaka, M., et al. (2017) · Suizo · doi:10.2958/suizo.32.16 · Cited by 3
Liang, Z., Li, P., Han, X., Zhang, S.-T., & Wei, Y.-Q. (2024) · Endoscopic Ultrasound · doi:10.1097/eus.0000000000000093 · Cited by 2
Survival benefit associated with screening of patients at elevated risk for pancreatic cancer
Kane, W. J., Haden, K., Martin, E. N., Shami, V. M., Wang, A. Y., Strand, D. S., Adair, S. J., Nagdas, S., Tsung, A., Zaydfudim, V. M., et al. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.27784 · Cited by 2
Peters, M. L. B., Eckel, A. L., Lietz, A., Seguin, C. L., Mueller, P. P., Hur, C., & Pandharipande, P. V. (2022) · Pancreatology · doi:10.1016/j.pan.2022.05.003 · Cited by 2
Role of routine check-up in the prognosis of patients with pancreatic cancer: A puzzling phenomenon
Song, C., Shen, Y., & Lu, Y. (2020) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2020.06.009 · Cited by 2
Endoscopy and endosonography in the diagnostics of pancreatic cancer
Shishin, K., Bystrovskaya, E., Nedoluzhko, I., Kovalenko, D., Pronina, G., & Orlova, M. (2019) · Annaly khirurgicheskoy gepatologii = Annals of HPB surgery · doi:10.16931/1995-5464.2019336-44 · Cited by 2
The endoscopist’s role in the diagnosis and management of pancreatic cancer
Lee, J. H., Cassani, L. S., Bhosale, P., & Ross, W. A. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1176910 · Cited by 3
Kano, S., Gonoi, W., Nakaya, M., Inui, S., Nakai, Y., Masuoka, S., Masumoto, T., Minami, M., Gaballah, A. H., & Abe, O. (2026) · Radiographics · doi:10.1148/rg.250085 · Cited by 1
Pancreatic Atrophy: A Narrative Review and Surgical Interpretation
Fujino, R., Okada, K.-I., Masugi, Y., Iwasaki, E., & Mori, M. (2026) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.70230 · Cited by 1
“Accordingly, MRI/magnetic resonance cholangiopancreatography and EUS of intrapancreatic fat deposition serve as sensitive tools for evaluating PPA lesion distribution [21, 35, 45–49].”
Carrara, S., Archibugi, L., Terrin, M., Secchettin, E., Luca, R. D., & Paiella, S. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.04.007 · Cited by 1
Diagnostic value of integrating salivary and blood miRNAs for pancreatic cancer detection
Wilson, P., & NONAKA, T. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1642727 · Cited by 1
Saba, H., Diwan, E. A., Sinan, H., Melki, D., Dbouk, M. H., Blackford, A. L., Chu, L. C. H., Shin, E. J., Canto, M. I., & Goggins, M. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100818 · Cited by 1
“The diagnostic yield of EUS and MRI for pancreatic lesions in patients undergoing pancreatic surveillance has been extensively studied, 9–14 but the significance of non-pancreatic incidental findings identified during pancreatic surveillance has not been extensively studied.”
Pancreatic Cancer Screening: A Narrative Review
Meziani, J., Fuhler, G. M., Bruno, M. J., Cahen, D. L., & Overbeek, K. A. (2024) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2024.08.001 · Cited by 2
Self-citationPankreaskarzinom – Screening oder Surveillance?
Sirtl, S., Vornhülz, M., Hofmann, F. O., Mayerle, J. V., & Beyer, G. (2023) · Die Radiologie · doi:10.1007/s00117-023-01227-3 · Cited by 2
Management des Peutz-Jeghers-Syndroms
Möslein, G. (2023) · Zentralblatt für Chirurgie · doi:10.1055/a-2109-3140 · Cited by 1
Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals
Labiner, A. J., Aronson, A., & Lucas, A. L. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.06.004 · Cited by 1
Comandatore, A., Balsano, R., Immordino, B., Arguedas, D., Capula, M., Baglio, R., Garajová, I., Malapelle, U., Morelli, L., & Giovannetti, E. (2022) · Critical reviews in oncology/hematology · doi:10.1016/j.critrevonc.2022.103659 · Cited by 1
Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer
Dall’Olio, T., Capurso, G., Terrin, M., Luca, R. D., Coluccio, C., Arcangeli, V., Milanetto, A. C., Butturini, G., Fantin, A., Barresi, L., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.35610
Levinson, E. J., Hilfrank, K., Rustgi, S., & Kastrinos, F. (2026) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2026.07.002
Okumura, K., Kozaka, K., & Kobayashi, S. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-10065-x
“Key metadata are summarized in Table 2 [21, 22, 38, 72].”
InfluentialHereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications
Marafioti, M., Patruno, M., Musarra, M., Silvestris, N., Funes, J. A. P., Omero, F., Sapuppo, E., Cianci, V., Calabrò, M., Irrera, N., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146404
“EUS and MRI have demonstrated good concordance in the assessment of pancreatic lesion size and anatomical location [169] and have been found to be complementary [170], with MRI being particularly sensitive for cystic lesions (such as branch-duct IPMNs) and EUS for solid lesions.”
Diagnostic Method Advancement to Improve the Prognosis of Pancreatic Ductal Adenocarcinoma
Sapkota, P., Kikuyama, M., & Honda, G. (2026) · Diagnostics · doi:10.3390/diagnostics16142286
“Hanrinck et al. compared EUS and MRI for pancreatic cancer surveillance in high-risk individuals and concluded that the two modalities are complementary rather than interchangeable [43].”
Jimbo, Y., Tomishima, K., Sano, K., Suzuki, A., Kiko, H., Arii, S., Okuaki, T., Hagiwara, H., Yamaguchi, Y., Ikoma, I., et al. (2026) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_91_26
Early Diagnosis of Cancer of the Pancreas: A Key Step in Improving Survival Rates
Malnick, S., Abdullah, A., & Mildiner, S. (2024) · SciBase Gastroenterology and Hepatology · doi:10.52768/scibasegastroenterolhepatol/1001
“MRCP provides a better determination of cyst communication with the main pancreatic duct [19] MRI may have less sensitivity in detecting small solid lesions as compared to EUS [20].”
BackgroundOppat, K. M., Bennett, F. J., & Maithel, S. K. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.04.012 · Cited by 1
Current role of endoscopic ultrasound for the evaluation of pancreatic diseases
Lee, Y. S. (2023) · Journal of Innovative Medical Technology · doi:10.61940/jimt.230009
Early detection of pancreatic adenocarcinoma.
Jonas, E., & Brand, M. (2023) · South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie · doi:10.36303/sajs.4145
Haimi, I., Sanoba, S. A., Everett, J. N., & Simeone, D. M. (2023) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2023.03.002 · Cited by 1
Pankreaskarzinom – Screening oder Surveillance: Was ergibt Sinn?
Sirtl, S., Vornhülz, M., Hofmann, F. O., Mayerle, J. V., & Beyer, G. (2022) · Die Gastroenterologie · doi:10.1007/s11377-022-00652-5
Diagnostik und klinisches Management prämaligner Erkrankungen des Pankreas
Buchholz, S. M., Ammer‐Herrmenau, C., Ellenrieder, V., & Neeße, A. (2022) · Der Internist · doi:10.1007/s00108-022-01308-w
Facteurs prédisposants de l’adénocarcinome pancréatique : quel est le rôle de l’imagerie ?
Vullierme, M., & Lagadec, M. (2016) · Journal de radiologie diagnostique et interventionnelle · doi:10.1016/j.jradio.2016.10.003
Reducing the Risk of and Screening for Pancreatic Cancer
Kothari, S., Kaul, V., & Kothari, T. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-37482-2_35-1
Chalhoub, J. M., & Andrawes, S. (2021) · Clinical gastroenterology · doi:10.1007/978-3-030-69940-6_8
Evaluation and Staging of Pancreaticobiliary Malignancy
Levy, M., & Al-Haddad, M. A. (2019) · Clinical Gastrointestinal Endoscopy · doi:10.1016/b978-0-323-41509-5.00062-1
Secondary Screening for Inherited Pancreatic Ductal Adenocarcinoma
Sheel, A., Nicholson, J., Sarantitis, I., Neoptolemos, J. P., & Greenhalf, W. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_63-1
Kleeff, J., Korc, M., Apte, M., la Vecchia, C., & Johnson, C. D. (2016) · doi:10.7326/0003-4819-95-5-668_1
Metadata
- Authors
- Harinck, F., Konings, I. C. A. W., Kluijt, I., Poley, J. W., van Hooft, J. E., van Dullemen, H. M., Nio, C. Y., Krak, N. C., Hermans, J. J., Aalfs, C. M., Wagner, A., Sijmons, R. H., Biermann, K., van Eijck, C. H., Gouma, D. J., Dijkgraaf, M. G. W., Fockens, P., & Bruno, M. J.
- Affiliations
- Erasmus MC (NL)
- The Netherlands Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
- University Medical Center Groningen (NL)
- Radboud University Medical Center (NL)
- Corresponding author
- Harinck, F
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-05-18
- Volume
- 65
- Issue
- 9
- Pages
- 1505-1513
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W1907808487
- Cited by
- 185
- References
- 0
- Citations by year
- 2026: 13 · 2025: 6 · 2024: 16 · 2023: 16 · 2022: 21 · 2021: 19 · 2020: 16 · 2019: 23 · 2018: 18 · 2017: 19 · 2016: 15 · 2015: 3
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- ZonMw (120520016)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- pancreatic cancer screening, endoscopic ultrasound, magnetic resonance imaging, pancreatic ductal adenocarcinoma, high-risk individuals, intraductal papillary mucinous neoplasm, pancreatic cysts, pancreatic intraepithelial neoplasia, solid pancreatic lesions, diagnostic agreement, early cancer detection
- MeSH terms
- Adult, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Netherlands, Pancreas, Pancreatic Cyst, Pancreatic Neoplasms, Prospective Studies, Cohort Studies, Endosonography, Carcinoma, Pancreatic Ductal, Early Detection of Cancer, Comparative Effectiveness Research, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
